7,622.92

+42.85

+0.57%

52,300.83

+530.52

+1.02%

25,603.66

+166.67

+0.66%

2,841.65

+29.80

+1.06%

4.8880

-0.0410

-0.83%

18.83

-0.59

-3.04%

3,978.20

+79.30

+2.03%

77,371.49

-482.50

-0.62%

Crude Oil Dec 26

96.54

-7.58

-7.28%

US Private Equity

10,850.63

-82.20

-0.75%

OTC Markets OTCPK - Delayed Quote USD

Fresenius SE & Co. KGaA (FSNUY)

13.71 +0.36 (+2.70%)

As of 10:20:56 AM EST. Market Open.

Fresenius and WuXi Biologics enter exclusive development agreement to expand biosimilars pipeline

PR Newswire 10h ago

FRE.DE

2269.HK

FRE.F
Is Fresenius SE KGaA (XTRA:FRE) Still A Bargain On Earnings?

Simply Wall St. 1d ago

FRE.DE
All You Need to Know About Fresenius SE & Co. (FSNUY) Rating Upgrade to Buy

Zacks 1mo ago

FSNUY
+2.70%
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?

Zacks 2mo ago

FRE.DE

FSNUF

FSNUY
+2.70%
Chemed (CHE) Tops Q2 Earnings and Revenue Estimates

Zacks 3mo ago

CHE

FSNUF

FSNUY
+2.70%
Ensign Group (ENSG) Q2 Earnings and Revenues Top Estimates

Zacks 3mo ago

ENSG

FSNUF

FSNUY
+2.70%
Fresenius establishes venture fund of more than €200 million to drive healthcare innovation

PR Newswire 3mo ago

FRE

FSNUY
+2.70%
FREA.F
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?

Zacks 5mo ago

FRE.DE

FSNUF

FSNUY
+2.70%
Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?

Zacks 5mo ago

FRE.DE

FSNUF

FSNUY
+2.70%
Vizient Expands Supply Assurance for IV Solutions Through Collaboration With Fresenius Kabi

Business Wire 27d ago

FRE.DE
Fresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansion

PR Newswire 1mo ago

FRE.DE
Fresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansion

PR Newswire 1mo ago

FRE.DE

Mobilize your Website

View Site in Mobile | Classic

Share by: